InnoUp Farma — Seed · approximately €600K

A €600,000 round closed to take oral paclitaxel for metastatic breast cancer and the oral peanut-allergy immunotherapy into Phase I trials. SODENA put in €267,500 and Inveready and the founders also invested. In June 2019 the company opened a €1M round on the Capital Cell crowdfunding platform that built on these commitments (more than €600K secured at the time), but no close of that campaign was reported.